Cell therapies represent an important advancement in our ability to treat difficult cancers, but continued exploration of this new modality will require new digital tools and equipment.
- PUPSIT In Cell & Gene Therapy: Risk Reduction Or Operational Complexity?
- Is Your AI Model Trustworthy And Credible In GMP Processes?
- May 2026 — CDMO Opportunities And Threats Report
- In Vivo Gene Editing Is Moving From Promise To Proof
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- FDA's Guidance On Cell And Gene CMC Codifies Flexibility
- Strategic Synthesis Of ASGCT And ASCO 2026
- Emerging Technologies In Aseptic Processing: Hype Vs. Operational Reality
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Lonza Nucleofector]( "Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT")
Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGTThis paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.
-
![antibody molecules-GettyImages-2165626333]( "ADC Development Grows More Complex — SPR Insights Bring Clarity")
ADC Development Grows More Complex — SPR Insights Bring ClarityExplore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Services For Cell Line Preparation And Storage")
Integrated Services For Cell Line Preparation And StorageExplore a comprehensive suite of services for the manufacture, characterization, and storage of cell banks as well as the advantages of working with an experienced partner.
-
![GettyImages-1935725164-disease-cell-blue]( "3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons")
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived NeuronsExplore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
![Cancer patient consulting with doctor-GettyImages-1217056000]( "Accelerating Approval Pathway For Phase III Ovarian Cancer Trial")
Accelerating Approval Pathway For Phase III Ovarian Cancer TrialA late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.
-
![GettyImages-2152658176 oncology, doctor, patient]( "5 Operational Gaps To Avoid CGT Patient Risks")
5 Operational Gaps To Avoid CGT Patient RisksExamine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.
-
![450_300-high_oxygen_demanding_microorganisms]( "Aerobic Cultivation Of High-Oxygen-Demand Microorganisms")
Aerobic Cultivation Of High-Oxygen-Demand MicroorganismsDiscover how oxygen-enriched conditions and smart feeding strategies boost microbial growth. Prevent oxygen limitation, improve productivity, and maintain control for high-density bioprocessing success.
-
![mRNA GettyImages-1356994684]( "Levers To Optimize The IVT Reaction For Increased mRNA Yield")
Levers To Optimize The IVT Reaction For Increased mRNA YieldMastering IVT yield requires balancing magnesium and nucleotide ratios. Learn how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production.
-
![cell-therapy-GettyImages-1494029118]( "Expanding The Capabilities Of Targeted Integration")
Expanding The Capabilities Of Targeted IntegrationSee the demonstration of precise, site‑specific integration of a 50 kb multi‑gene construct into human iPSCs, overcoming size limits of traditional genome‑engineering approaches.
-
![Genomic sequencing, molecular biology, and genetic data analysis-GettyImages-2153790378]( "Sample Quality Control In The Whole-Genome Sequencing Workflow")
Sample Quality Control In The Whole-Genome Sequencing WorkflowSee how consistent QC checkpoints show how even degraded samples can produce strong sequencing results when monitored with reliable sizing, quantification, and workflow‑specific thresholds.
NEWSLETTER ARCHIVE
- 06.26.26 -- Reimagining In Vivo Gene Editing Through Base Editing And Targeted Delivery
- 06.25.26 -- Fixing The Fragmentation In Outsourced Pharma
- 06.25.26 -- Better Biopharma's Editors' Roundtable — A Midyear Look At The 2026 Life Sciences Industry
- 06.24.26 -- Smarter risk management for single-use and filtration systems.
- 06.24.26 -- What's Driving Cell & Gene Therapy Forward? Key Trends & Insights
- In Vivo Gene Editing Is Moving From Promise To Proof
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
